These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11806607)

  • 1. Note on comparability of MicroCog test forms.
    Lopez SJ; Edwards LM; Floyd RK; Magyar-Moe J; Rehfeldt JD; Ryder JA
    Percept Mot Skills; 2001 Dec; 93(3):825-8. PubMed ID: 11806607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor structure of MicroCog in a clinical sample.
    Lopez SJ; Sumerall SW; Ryan JJ
    Appl Neuropsychol; 2002; 9(3):183-6. PubMed ID: 12584084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroCog: assessment of cognitive functioning.
    Elwood RW
    Neuropsychol Rev; 2001 Jun; 11(2):89-100. PubMed ID: 11572473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of overinclusion in schizophrenia by a computer-assisted version of the Concept Overinclusion test].
    Kawohl W; Winzer C; Stadtmann S; Theodoridou A; Maercker A
    Neuropsychiatr; 2010; 24(4):259-66. PubMed ID: 21176707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying and monitoring cognitive deficits in clinical populations using Automated Neuropsychological Assessment Metrics (ANAM) tests.
    Kane RL; Roebuck-Spencer T; Short P; Kabat M; Wilken J
    Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S115-26. PubMed ID: 17101258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between two short cognitive tests and a WISC-III short form using a sample of adolescent inpatients.
    Connery S; Katz D; Kaufman AS; Kaufman NL
    Psychol Rep; 1996 Jun; 78(3 Pt 2):1373-8. PubMed ID: 8816052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial construct validation of frequently employed ANAM measures through structural equation modeling.
    Short P; Cernich A; Wilken JA; Kane RL
    Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S63-77. PubMed ID: 17145163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic variables and microCog performance: relationships for VA patients under treatment for substance abuse.
    Lopez SJ; Ryan JJ; Sumerall SW; Lichtenberg JW; Glasnapp D; Krieshok TS; Van Fleet JN
    Psychol Rep; 2001 Feb; 88(1):183-8. PubMed ID: 11293027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory.
    Falconer DW; Cleland J; Fielding S; Reid IC
    Psychol Med; 2010 Jun; 40(6):1017-25. PubMed ID: 19775495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate length neuropsychological screening of impairment among psychoactive substance-abusing patients: a comparison of two batteries.
    Fals-Stewart W
    J Subst Abuse; 1996; 8(1):1-17. PubMed ID: 8743765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary psychometric analysis of a computer-assisted administration of the Telephone Interview of Cognitive Status-modified.
    Buckwalter JG; Crooks VC; Petitti DB
    J Clin Exp Neuropsychol; 2002 Apr; 24(2):168-75. PubMed ID: 11992199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative analysis of inaccurate responses on the Hooper Visual Organization Test.
    Lopez MN; Lazar MD; Imperio SM
    Percept Mot Skills; 2005 Jun; 100(3 Pt 1):695-702. PubMed ID: 16060429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity issues in using the Millon-II with substance abusers.
    Bishop DR
    Psychol Rep; 1993 Aug; 73(1):27-33. PubMed ID: 8367567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing change with the Automated Neuropsychological Assessment Metrics (ANAM): issues and challenges.
    Roebuck-Spencer T; Sun W; Cernich AN; Farmer K; Bleiberg J
    Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S79-87. PubMed ID: 17118623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMINDS does not have identical tests to the CATIE and MATRICS batteries. Commentary on O'Halloran et al.
    Kern RS; Green MF; Nuechterlein KH; Keefe RS
    Schizophr Res; 2009 Feb; 107(2-3):327-9; author reply 330-1. PubMed ID: 19013770
    [No Abstract]   [Full Text] [Related]  

  • 17. Incomplete psychometric equivalence of scores obtained on the manual and the computer version of the Wisconsin Card Sorting Test?
    Steinmetz JP; Brunner M; Loarer E; Houssemand C
    Psychol Assess; 2010 Mar; 22(1):199-202. PubMed ID: 20230165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construct validity of the Babcock Story Recall Test.
    Horner MD; Teichner G; Kortte KB; Harvey RT
    Appl Neuropsychol; 2002; 9(2):114-6. PubMed ID: 12214822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ARES test system for palm OS handheld computers.
    Elsmore TF; Reeves DL; Reeves AN
    Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S135-44. PubMed ID: 17166694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NeuroCogFX--a computer-based neuropsychological assessment battery for the follow-up examination of neurological patients].
    Fliessbach K; Hoppe C; Schlegel U; Elger CE; Helmstaedter C
    Fortschr Neurol Psychiatr; 2006 Nov; 74(11):643-50. PubMed ID: 17103364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.